Wegovy and Zepbound Denied? How to Appeal Weight Loss Medication Denials

Your doctor prescribed Wegovy or Zepbound. You went to the pharmacy, maybe even felt a little hopeful. Then the call came: denied. Not covered. Prior authorization required. Or worse, your plan simply excludes weight management medications altogether.

If that happened to you, you are far from alone. Only 39% of surveyed payers currently cover GLP-1 medications for obesity, and even among patients who do have coverage, over 88% still face prior authorization requirements before they can fill a single prescription. The system is stacked against you from the start.

But here is the thing. You have the right to appeal. And appeals can work, especially when you understand exactly why the denial happened and how to counter it with the right evidence. This guide walks you through the entire process, from decoding your denial letter to building a case your insurer will have a hard time refusing.

What Are Wegovy and Zepbound, and Why Do They Matter?

Wegovy (semaglutide), manufactured by Novo Nordisk, is a GLP-1 receptor agonist that was FDA-approved on June 4, 2021, for chronic weight management in adults with obesity (BMI of 30 or greater) or overweight (BMI of 27 or greater) who have at least one weight-related comorbidity such as high blood pressure, type 2 diabetes, or high cholesterol. Wegovy has also received FDA approval for cardiovascular risk reduction.

Zepbound (tirzepatide), manufactured by Eli Lilly, received its FDA approval on November 8, 2023, for chronic weight management. It is the first dual GIP/GLP-1 receptor agonist, meaning it targets two gut hormone pathways instead of one. Its efficacy was demonstrated in the SURMOUNT clinical trials. Zepbound has also been approved for obstructive sleep apnea.

These are not fringe treatments. They are FDA-approved therapies backed by rigorous clinical trials. Yet insurers continue to deny them at staggering rates. Understanding why is the first step toward fighting back.

Why GLP-1 Medications for Obesity Get Denied So Often

The denial problem is getting worse, not better. In 2026, the number of people with no commercial coverage for Wegovy increased 42% compared to 2025, leaving more than 41 million individuals without access. Zepbound saw a 12% rise in no-coverage plans over the same period. That is millions of people whose doctors have prescribed a medication their insurance simply refuses to pay for.

The root cause? Many insurers still treat obesity as a lifestyle issue rather than a chronic disease. Despite the American Medical Association recognizing obesity as a disease back in 2013, insurance companies have been slow to update their coverage policies. The result is a coverage landscape riddled with exclusions, restrictions, and bureaucratic hoops.

There is also the cost factor. GLP-1 medications carry high list prices, and insurers use prior authorization, step therapy, and outright exclusions to limit how many prescriptions they approve. For patients, this translates into denials that feel arbitrary and deeply frustrating.

The Ozempic and Mounjaro Connection: Same Drug, Different Coverage

This trips up a lot of people, so let us clear it up. Ozempic contains the same active ingredient as Wegovy (semaglutide), and Mounjaro contains the same active ingredient as Zepbound (tirzepatide). The difference is not in the molecule. It is in the FDA-approved indication.

Ozempic and Mounjaro are FDA-approved for type 2 diabetes. Because diabetes is universally recognized as a covered medical condition, insurance companies cover these medications far more readily. Wegovy and Zepbound, on the other hand, are approved specifically for chronic weight management, and that is where coverage falls apart.

If you have type 2 diabetes or another eligible diagnosis like cardiovascular disease, your doctor may be able to prescribe the diabetes-indicated version instead. That is a conversation to have with your healthcare provider, not a decision to make on your own. But it is worth knowing that this distinction exists, because it shapes nearly every coverage decision insurers make around these drugs.

Medicare and GLP-1 Medications: Where Things Stand

If you are on Medicare, the news is particularly difficult. Medicare currently does not cover anti-obesity medications. Full stop. The Treat and Reduce Obesity Act has been reintroduced in Congress multiple times, but as of this writing, it has not passed into law. And in April 2025, CMS chose not to include obesity drug coverage in its 2026 final rule.

There is one important exception. Medicare will cover GLP-1 medications if they are prescribed for an eligible diagnosis other than obesity, such as type 2 diabetes or cardiovascular disease. If you have one of these conditions, work with your doctor to ensure the prescription reflects the appropriate diagnosis.

The Five Most Common Denial Reasons

Before you can fight a denial, you need to understand exactly what your insurer is saying and why. Denial letters can be confusing, but they almost always fall into one of these five categories.

1. Classified as a "Lifestyle" Medication

This is the most common and the most infuriating. Your insurer says weight management is a lifestyle choice, not a medical necessity, and therefore the medication is not covered. Never mind the FDA approval. Never mind the clinical evidence. They have decided obesity is not a disease worth treating with medication.

2. BMI Threshold Not Met

Your plan may require a BMI of 30 or higher (or 27+ with a comorbidity) to approve coverage. Sometimes the documentation submitted does not clearly reflect your BMI, or the insurer has set a higher threshold than the FDA label. If your BMI is borderline, make sure your records include the most recent and accurate measurements.

3. Plan Exclusion for Weight Management Drugs

Some plans have a blanket exclusion for all anti-obesity medications. This is not a prior authorization denial. It is a coverage exclusion, meaning the plan was never designed to cover these drugs at all. This is the hardest type of denial to overturn, but external review is still an option in many states.

4. Step Therapy Requirements

Your insurer wants you to try cheaper alternatives first. For GLP-1s, this often means documenting that you have tried and failed at structured diet and exercise programs, behavioral counseling, or older weight loss medications. The key word is "documented." If your doctor verbally told you to eat better and move more, that probably will not satisfy the step therapy requirement.

5. Prior Authorization Not Obtained

Over 88% of those with coverage for GLP-1s still face prior authorization requirements. If your doctor prescribed the medication without getting prior approval from your insurer, the claim will be denied. The good news: this is often the easiest denial to fix. Your doctor can submit the prior authorization retroactively in many cases.

Building Your Medical Necessity Argument

Here is a hard truth from KFF research: consumers appeal only about 1% of insurance denials. One percent. That means 99 out of 100 people who get denied simply accept it and move on. But the data also shows that appeal success rates can be significant when strong medical documentation is provided. The people who fight back often win.

The core of any successful appeal is a medical necessity argument. You need to convince a medical reviewer, usually a physician employed by or contracted with the insurer, that this specific medication is not just helpful but necessary for your health. Here is how to build that case.

• •Your denial letter (read it carefully and identify the specific reason code)
• •Complete medical records showing your weight history, BMI measurements, and weight-related conditions
• •Documentation of previous weight loss attempts (diet programs, exercise regimens, behavioral counseling, prior medications)
• •Lab results showing weight-related health impacts (A1C, lipid panels, blood pressure readings, sleep studies)
• •Your doctor's letter of medical necessity explaining why this specific medication is appropriate for you
• •Clinical studies supporting the use of Wegovy or Zepbound for your specific situation
• •Your insurance plan's Summary of Benefits and coverage criteria for the medication

What to Include in Your Appeal Letter

Your appeal letter is the centerpiece of your case. It needs to be clear, organized, and directly responsive to the reason your insurer gave for the denial. Do not write a general "please reconsider" letter. Address their specific objection head-on.

Structure Your Letter Like This

• •Opening: State your name, policy number, claim number, date of denial, and the medication denied. Reference the specific denial reason from your denial letter.
• •Medical history: Summarize your weight history, BMI, and weight-related conditions. Include specific dates, measurements, and diagnoses.
• •Previous treatments tried and failed: Document every diet, exercise program, behavioral intervention, or medication you have tried. Include dates, durations, and outcomes. This directly counters step therapy denials.
• •Why this medication is medically necessary: Explain why Wegovy or Zepbound is the appropriate treatment for your condition. Reference the FDA approval, clinical trial data, and your doctor's clinical judgment.
• •Supporting evidence: Reference your doctor's letter of medical necessity, relevant clinical studies, and any applicable clinical guidelines.
• •Closing: Request a specific action (approval of the medication), state your intent to pursue external review if the internal appeal is denied, and include your contact information.

Writing a strong appeal letter takes time, and it is not easy to be your own advocate when you are frustrated and discouraged. If you want help putting the pieces together, tools like Appealio can walk you through the process and help you build a complete appeal package. But whether you use a service or do it yourself, the key is the same: be specific, be thorough, and directly counter the insurer's stated reason for denial.

Countering Each Denial Type

If Denied as a "Lifestyle" Medication

This is where the FDA approval is your strongest weapon. Wegovy was FDA-approved for chronic weight management, not cosmetic weight loss. Zepbound went through the same rigorous approval process and was additionally approved for obstructive sleep apnea. Reference the FDA approval dates, the clinical trial data, and the fact that the American Medical Association classifies obesity as a chronic disease. If you have weight-related comorbidities like hypertension, sleep apnea, or joint disease, document every single one.

If Denied for BMI Threshold

Make sure your medical records include a recent, clearly documented BMI measurement. If your BMI fluctuates near the threshold, ask your doctor to document the highest recent measurement and include a note explaining that BMI can vary. Also check whether your plan uses the same threshold as the FDA label. Some insurers set the bar higher than the FDA requires.

If Denied for Plan Exclusion

Blanket exclusions are the toughest to overturn through internal appeal. But do not stop there. Many states allow external review even for plan exclusions, and some state insurance commissioners have ruled that excluding all anti-obesity medications is discriminatory. Check your state's external review rights. If you have an employer-sponsored plan, consider raising the issue with your HR department, as plan design decisions are often made at the employer level and can sometimes be changed.

If Denied for Step Therapy

Document everything you have tried. If you did Weight Watchers for six months, get a letter from the program confirming your enrollment and results. If you worked with a nutritionist, get their clinical notes. If you tried older medications like phentermine and they did not work or caused side effects, document that too. The more thoroughly you can show that you have tried and failed at less intensive approaches, the stronger your case becomes.

External Review: When Your Internal Appeal Is Denied

If your internal appeal is denied, do not give up. You have the right to an external review, where an independent third party, not employed by your insurance company, reviews your case. Under the Affordable Care Act, most health plans are required to offer external review for denied claims.

External review is often your best chance of overturning a denial, because the reviewer is not financially incentivized to deny your claim. The process varies by state, but generally you need to request external review within four months of your internal appeal denial. The independent reviewer will examine your medical records, your doctor's recommendation, and the clinical evidence, and make a binding decision.

To request external review, contact your state's Department of Insurance or check your internal appeal denial letter for instructions. Many states have online portals where you can submit your request. Include all of the documentation from your internal appeal, plus any additional evidence you have gathered since then.

Practical Tips That Make a Difference

• •Read your denial letter word by word. The specific language tells you exactly what argument the insurer is making and what you need to counter.
• •Request your plan's specific coverage criteria for Wegovy or Zepbound. Call the number on the back of your insurance card and ask for the "medical policy" or "coverage determination criteria" for the drug. This tells you exactly what boxes you need to check.
• •Ask your doctor to write a detailed letter of medical necessity, not a generic one. It should reference your specific health history, failed treatments, and why this medication is clinically appropriate for you personally.
• •Keep a timeline of every call, letter, and fax. Note the date, the person you spoke with, and what was said. This paper trail is invaluable if you need to escalate.
• •Do not miss your deadlines. Internal appeal deadlines vary by plan but are often 180 days from the denial. External review deadlines are typically four months from the internal appeal denial. Missing a deadline can forfeit your right to appeal.
• •If you feel overwhelmed, you are not the only one. Platforms like Appealio exist specifically to help patients navigate this process, from understanding denial letters to assembling appeal packages. You do not have to figure this all out alone.

Common Mistakes to Avoid

• •Do not accept the denial without reading the letter. Many people throw the letter away or assume nothing can be done. The denial letter contains the specific reason and your appeal rights.
• •Do not write an emotional appeal without evidence. Reviewers make decisions based on medical documentation and clinical criteria, not stories about how the denial made you feel.
• •Do not let your doctor submit a one-line letter. A letter that says "patient needs Wegovy" is not enough. It needs to include your diagnosis, BMI, comorbidities, failed treatments, and clinical rationale.
• •Do not confuse Wegovy with Ozempic or Zepbound with Mounjaro when communicating with your insurer. They are different products with different approvals and different coverage rules.
• •Do not wait until the last day to file. Give yourself time to gather documentation, get your doctor's letter, and put together a thorough appeal.

You Have More Power Than You Think

The insurance denial system counts on one thing above all else: that you will give up. And the numbers prove it. Only about 1% of denials are appealed. Insurers know this. They know that most people will read the denial letter, feel defeated, and never push back.

But you are still reading this, which means you are not most people. You are someone who is willing to fight for the treatment your doctor prescribed and the care you deserve.

The appeal process is not quick. It is not easy. But it is your right, and when patients come armed with strong medical documentation, specific clinical evidence, and a well-structured argument, appeals succeed far more often than the insurance companies want you to believe.

Start with your denial letter. Understand what it says. Gather your records. Talk to your doctor. And file that appeal.

A denial is not a final answer. It is the beginning of a conversation, and you get to have the last word.